The insulin-induced increase of guanosine-3′,5′-cyclic monophosphate in human platelets is mediated by nitric oxide

Diabetes

Volumn 45, Issue 6, 1996, Pages 768-770

  Trovati, Mariella ^a   Massucco, Paola ^a   Mattiello, Luigi ^a   Piretto, Valentina ^a   Cavalot, Franco ^a   Mularoni, Elena ^a   Anfossi, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYCLIC GMP; N(G) METHYLARGININE; NITRIC OXIDE; RECOMBINANT HUMAN INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

ADULT; ANALYSIS OF VARIANCE; ARGININE; BLOOD PLATELETS; CYCLIC GMP; ENZYME INHIBITORS; FEMALE; HUMANS; INSULIN; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; RECOMBINANT PROTEINS;

EID: 0029950985     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.6.768     Document Type: Article

References (12)

1. Trovati M, Anfossi G, Cavalot F, Massucco P, Mularoni E, Schinco P, Tamponi G, Emanuelli G: Studies on mechanisms involved in hypoglycemia-induced platelet activation. Diabetes 35:818-825, 1986
2. Trovati M, Anfossi G, Cavalot F, Massucco P, Mularoni E, Emanuelli G: Insulin directly reduces platelet sensitivity to aggregating agents: studies in vitro and in vivo. Diabetes 37:780-786, 1988
3. Trovati M, Massucco P, Mattiello L, Mularoni E, Cavalot F, Anfossi G: Insulin increases guanosine-3′,5′-cyclic monophosphate in human platelets: a mechanism involved in the insulin anti-aggregating effect. Diabetes 43:1015-1019, 1994
4. Trovati M, Anfossi G, Mularoni E, Massucco P, Bosia A, Emanuelli G: Insulin reduces platelet sensitivity to platelet activating factor in washed human platelets resuspended in a calcium-free medium. Diabetes Metab Nutr 2:151-153, 1989
5. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ: Evidence for the inhibitory role of guanosine-3′,5′-cyclic monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57:946-955, 1981
6. Radomsky MW, Palmer RMJ, Moncada S: An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 87:5193-5197, 1990
7. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron A: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest 94:1172-1179, 1994
8. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P: Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 94:2511-2515, 1994
9. Trovati M, Massucco P, Mattiello L, Cavalot F, Mularoni E, Hahn A, Anfossi G: Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone. Diabetologia 38:936-941, 1995
10. Anfossi G, Massucco P, Mularoni E, Cavalot F, Mattiello L, Trovati M: Organic nitrates that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost. Prostaglandins Leukotrienes Essent Fatty Acids 49:839-845, 1993
11. Trovati M, Mularoni E, Burzacca S, Ponziani MC, Massucco P, Mattiello L, Piretto V, Cavalot F, Anfossi G: Impaired insulin-induced platelet anti-aggregating effect in obesity and in obese non-insulin-dependent diabetes mellitus. Diabetes 44:1318-1322, 1995
12. Colwell JA, Gisinger C, Klein R: Altered platelet function in diabetes mellitus: effect of glycemic regulation and antiplatelet agents. In Hyperglycemia, Diabetes, and Vascular Diseases. Ruderman N, Williamson J, Brownlee M, Eds. New York, Oxford, Oxford University Press, 1992, p. 30-47